ARCHIVES

Therapeutic Modalities Improve Patient Quality of Life In Trials

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

January 3, 1992

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990

Flexibility OK In Paying Grants If Justified, Upton Affirms

September 1, 1978

Pepper Committee, Impressed By Progress Reports, Promises Help With NCI Funding

June 29, 1979

NCI Renews City of Hope’s Comprehensive Cancer Center Designation.

May 30, 2008

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008